Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on April 2, 2025
Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting
GlobeNewswire
·
April 2, 2025
NEWTON, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer …
Lantronix Named to CRN 2025 Internet of Things 50 List
GlobeNewswire
·
April 2, 2025
IRVINE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Lantronix Inc. (NASDAQ: LTRX), a global leader of compute and connectivity for IoT solutions enabling Edge AI Intelligence, today announced it has been recognized on the 2025 Internet of Things (IoT) 50 …
Global Helium Corp. Announces Sale of Standing Well and Lands in Montana
GlobeNewswire
·
April 2, 2025
CALGARY, Alberta, April 02, 2025 (GLOBE NEWSWIRE) -- Global Helium Corp. ("HECO" or the "Company") (CSE: HECO, OTC: HECOF) is pleased to announce the successful sale of one standing well and one section of associated mineral rights located in the Rudyard …
Investigators to Present Clinical Trial Results Showing Neflamapimod Slows Clinical Progression in Dementia with Lewy Bodies in Oral Presentation at AD/PD™ 2025
GlobeNewswire
·
April 2, 2025
During the first 16 weeks of the Extension phase of the RewinD-LB clinical study neflamapimod slowed clinical progression compared to controls, as assessed by Clinical Dementia Rating Sum of Boxes (CDR-SB) and Clinical Global Impression of Change (CGIC) …
SANTO TOMAS PROJECT MOVES FORWARD
GlobeNewswire
·
April 2, 2025
VANCOUVER, Canada, April 02, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO, OTC: ORRCF) (“Oroco” or the “Company”) Last week in Culiacan, Sinaloa, Craig Dalziel, Oroco's Chairman, and other members of Oroco’s Senior Management Team met with …
Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference
GlobeNewswire
·
April 2, 2025
CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and …
Sophos Report: In 56% of Sophos IR and MDR Cases, Adversaries Logged In, Instead of Breaking In
GlobeNewswire
·
April 2, 2025
IR and MDR Cases Highlight Attackers Are Exfiltrating Data in Just Three Days Compromised Credentials Top Root Causes for Second Year OXFORD, U.K., April 02, 2025 (GLOBE NEWSWIRE) -- Sophos, a global leader of innovative security solutions for defeating …
Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial
GlobeNewswire
·
April 2, 2025
STAFFORD, Texas, April 02, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy …
Perceptyx Launches First ‘Experience-Aware’ AI Coaching Agent
GlobeNewswire
·
April 2, 2025
TEMECULA, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Perceptyx, the global leader in employee listening and actioning for a better workplace, today launched AI Coach, the first AI-powered coaching agent to measurably improve business outcomes. Uniquely …
IceMOS Technology Closes $22 Million Series E Investment to Fund Launch of New Power Semiconductor Device Technology mSJMOS
GlobeNewswire
·
April 2, 2025
PARADISE VALLEY, Ariz., April 02, 2025 (GLOBE NEWSWIRE) -- Semiconductor manufacturer, IceMOS Technology Corporation today announced it has completed Series E funding from a London-based investor, 57 Stars LLC , and earlier stage USA investors. The company …